Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Wilson Medicine Company, a drug manufacturer, received an FDA Warning Letter on September 10, 2018. While the specific violations are not detailed in the available metadata, the letter indicates regulatory concerns related to drug manufacturing or marketing practices. The warning falls under FDA's drug product oversight, though the specific issuing office and violation count are not specified in the available information.